Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | OR2A9P///OR2A20P///OR2A5 |
| Upstream (Parents) |
|---|
| (<<) RASL12 → OR2A9P///OR2A20P///OR2A5 |
| (<<) MCM7 → OR2A9P///OR2A20P///OR2A5 |
| (<<) INADL → OR2A9P///OR2A20P///OR2A5 |
| (<<) JUND → OR2A9P///OR2A20P///OR2A5 |
| (<<) GOLGA1 → OR2A9P///OR2A20P///OR2A5 |
| Downstream (Children) |
|---|
| OR2A9P///OR2A20P///OR2A5 → KHDC1L///KHDC1 (>>) |
| OR2A9P///OR2A20P///OR2A5 → GPR110 (>>) |
| OR2A9P///OR2A20P///OR2A5 → USP49 (>>) |
| OR2A9P///OR2A20P///OR2A5 → C1QL1 (>>) |
